Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Non-melanoma Skin Cancer
and you are
over 18
years old
-
The phase for this study is not defined.
Show me locations

The purpose

This research study will test how well one topical medications work to prevent the development of non-melanoma skin cancers by reversing certain biomarkers in the skin. This study is also looking at the optimal dose of a medication in a small number of people. Biomarkers are molecules that are found in the body and inside of cells. Some biomarkers are associated with specific diseases such as skin cancer. In this study, one topical medication will be evaluated; diclofenac. Diclofenac and is approved by the Food and Drug Administration (FDA) for other uses. 24 patients will be enrolled in this study by University of Alabama at Birmingham.

Provided treatments

  • Drug: topical diclofenac daily
  • Drug: placebo
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02636569. The sponsor of the trial is University of Alabama at Birmingham and it is looking for 24 volunteers for the current phase.
Official trial title:
Topical Chemoprevention of Skin Cancer Biomarkers